Tag Archives: Brigham and Women’s Hospital (BWH)

Using Google Glass to monitor organs-on-chips

Google Glass : Explorer version Credit: Dan Leveille, twitter.com/danlev Courtesty: Wikimedi

Google Glass: Explorer Edition Credit: Dan Leveille, twitter.com/danlev Courtesy: Wikimedia

Researchers have introduced Google Glass as a new application for monitoring and controlling organs-on-chips according to a March 18, 2016 news item on ScienceDaily,

Investigators from Brigham and Women’s Hospital (BWH [Boston, Massachussetts]) have developed hardware and software to remotely monitor and control devices that mimic the human physiological system. Devices known as organs-on-chips allow researchers to test drug compounds and predict physiological responses with high accuracy in a laboratory setting. But monitoring the results of such experiments from a conventional desktop computer has several limitations, especially when results must be monitored over the course of hours, days or even weeks.

Google Glass, one of the newest forms of wearable technology, offers researchers a hands-free and flexible monitoring system. To make Google Glass work for their purposes, Zhang et al. custom developed hardware and software that takes advantage of voice control command (“ok glass”) and other features in order to not only monitor but also remotely control their liver- and heart-on-a-chip systems. Using valves remotely activated by the Glass, the team introduced pharmaceutical compounds on liver organoids and collected the results. …

A March 18, 2016 BWH press release on EurekAlert, which originated the news item, describes the hopes for this new combined platform,

“We believe such a platform has widespread applications in biomedicine, and may be further expanded to health care settings where remote monitoring and control could make things safer and more efficient,” said senior author Ali Khademhosseini, PhD, Director of the Biomaterials Innovation Research Center at BWH.

“This may be of particular importance in cases where experimental conditions threaten human life – such as work involving highly pathogenic bacteria or viruses or radioactive compounds,” said leading author, Shrike Zhang, PhD, also of BWH’s Biomedical Division.

Here’s a link to and a citation for the paper,

Google Glass-Directed Monitoring and Control of Microfluidic Biosensors and Actuators by Yu Shrike Zhang, Fabio Busignani, João Ribas, Julio Aleman, Talles Nascimento Rodrigues, Seyed Ali Mousavi Shaegh, Solange Massa, Camilla Baj Rossi, Irene Taurino, Su-Ryon Shin, Giovanni Calzone, Givan Mark Amaratunga, Douglas Leon Chambers, Saman Jabari, Yuxi Niu, Vijayan Manoharan, Mehmet Remzi Dokmeci, Sandro Carrara, Danilo Demarchi, & Ali Khademhossein. Scientific Reports 6, Article number: 22237 (2016) doi:10.1038/srep22237 Published online: 01 March 2016

This paper is open access.

Gluing a broken heart back together

The Jan. 8, 2014 news item on ScienceDaily doesn’t identify which creature(s) may have inspired the heart glue developed by researchers from Brigham and Women’s Hospital (BWH), Boston Children’s Hospital, and Massachusetts Institute of Technology (MIT),

When a child is born with a heart defect such as a hole in the heart, the highly invasive therapies are challenging due to an inability to quickly and safely secure devices inside the heart. Sutures take too much time to stitch and can cause stress on fragile heart tissue, and currently available clinical adhesives are either too toxic or tend to lose their sticking power in the presence of blood or under dynamic conditions, such as in a beating heart.

“About 40,000 babies are born with congenital heart defects in the United States annually, and those that require treatment are plagued with multiple surgeries to deliver or replace non-degradable implants that do not grow with young patients,” says Jeffrey Karp, PhD, Division of Biomedical Engineering, BWH Department of Medicine, co-senior study author of a new study that may improve how surgeons treat congenital heart defects.

In the preclinical study, researchers from Boston Children’s Hospital, BWH and Massachusetts Institute of Technology (MIT) developed a bio-inspired adhesive that could rapidly attach biodegradable patches inside a beating heart — in the exact place where congenital holes in the heart occur, such as with ventricular heart defects.

The Jan. 8, 2014 BWH news release on EurekAlert, which originated the news item, discusses the use of adhesives for repair in the body and some of the specifics of this particular application,

Recognizing that many creatures in nature have secretions that are viscous and repel water, enabling them to attach under wet and dynamic conditions, the researchers developed a material with these properties that also is biodegradable, elastic and biocompatible. According to the study authors, the degradable patches secured with the glue remained attached even at increased heart rates and blood pressure.

“This adhesive platform addresses all of the drawbacks of previous systems in that it works in the presence of blood and moving structures,” says Pedro del Nido, MD, Chief of Cardiac Surgery, Boston Children’s Hospital, co-senior study author. “It should provide the physician with a completely new, much simpler technology and a new paradigm for tissue reconstruction to improve the quality of life of patients following surgical procedures.”

Unlike current surgical adhesives, this new adhesive maintains very strong sticking power when in the presence of blood, and even in active environments.

“This study demonstrated that the adhesive was strong enough to hold tissue and patches onto the heart equivalent to suturing,” says the study’s co-first author Nora Lang, MD, Department of Cardiac Surgery, Boston Children’s Hospital. “Also, the adhesive patch is biodegradable and biocompatible, so nothing foreign or toxic stays in the bodies of these patients.”

Importantly, its adhesive abilities are activated with ultraviolent (UV) light, providing an on-demand, anti-bleeding seal within five seconds of UV light application when applied to high-pressure large blood vessels and cardiac wall defects.

“When we attached patches coated with our adhesive to the walls of a beating heart, the patches remained despite the high pressures of blood flowing through the heart and blood vessels,” says Maria N. Pereira, PhD, Division of Biomedical Engineering, BWH Department of Medicine, co-first study author.

The researchers note that their waterproof, light-activated adhesive will be useful in reducing the invasiveness of surgical procedures, as well as operating times, in addition to improving heart surgery outcomes.

As to which creature(s) may have inspired the glue, perhaps this offers a hint,

The adhesive technology (and other related platforms) has been licensed to a start-up company, Gecko Biomedical, based in Paris. [emphasis mine] The company has raised 8 million Euros in their recently announced Series A financing round and expects to bring the adhesive to the market within two to three years.

The last time geckos and adhesives were mentioned here was in a Jan. 2, 2014 posting titled: Simon Fraser University’s (Canada) gecko-type robots and the European Space Agency.

Getting back to the heart glue, here’s an image illustrating the researchers’ work,

Caption: The waterproof, light-activated glue developed by researchers at Brigham and Women's Hospital, Boston Children's Hospital and Massachusetts Institute of Technology can successfully secure biodegradable patches to seal holes in a beating heart. Credit: Karp Laboratory

Caption: The waterproof, light-activated glue developed by researchers at Brigham and Women’s Hospital, Boston Children’s Hospital and Massachusetts Institute of Technology can successfully secure biodegradable patches to seal holes in a beating heart.
Credit: Karp Laboratory

For the interested, here’s a link to and a citation for the paper,

A Blood-Resistant Surgical Glue for Minimally Invasive Repair of Vessels and Heart Defects by Nora Lang, Maria J. Pereira, Yuhan Lee, Ingeborg Friehs, Nikolay V. Vasilyev, Eric N. Feins, Klemens Ablasser, Eoin D. O’Cearbhaill, Chenjie Xu, Assunta Fabozzo, Robert Padera, Steve Wasserman, Franz Freudenthal, Lino S. Ferreira, Robert Langer, Jeffrey M. Karp, and Pedro J. del Nido. Sci Transl Med 8 January 2014: Vol. 6, Issue 218, p. 218ra6 Sci. Transl. Med. DOI: 10.1126/scitranslmed.3006557

This paper is behind a paywall.